fb

European Study Finds Combined Birth Control Pills Triple Stroke Risk in Young Women

by | Jun 27, 2025

A multinational analysis links synthetic estrogen contraceptives to a significant increase in cryptogenic ischemic strokes.

By yourNEWS Media Newsroom

A newly released European study has found that young women who take combined oral contraceptives face a tripled risk of cryptogenic ischemic stroke—those with no identifiable cause. Presented at the 2025 European Stroke Organization Conference, the study analyzed health data from more than 500 women across 14 countries, raising urgent questions about the long-term safety of hormonal birth control and the transparency of pharmaceutical risk disclosure.

Researchers behind the study evaluated 268 women who had experienced cryptogenic strokes and compared them to 268 stroke-free women between the ages of 18 and 49. The use of estrogen-containing birth control pills was found to significantly elevate stroke risk, even after adjusting for variables such as hypertension, smoking, and migraine history.

“Our findings confirm earlier evidence linking oral contraceptives to stroke risk,” said Dr. Mine Sezgin of Istanbul University, who led the study. “What’s particularly notable is that the association remained strong even when accounting for other known risk factors, which suggests there may be additional mechanisms involved — possibly genetic or biological.”

The study was conducted under the broader SECRETO project, which investigates causes of unexplained stroke in younger populations. According to researchers, even low-dose formulations containing synthetic estrogen, such as ethinylestradiol, were linked to elevated stroke risk—despite falling within commonly prescribed safety guidelines.

A summary of the findings was published by The Epoch Times, which highlighted that these “low-dose” versions are often marketed as safer alternatives, yet still appear to significantly increase clotting potential.

Stroke Rates Rising Among Young Adults

Ischemic strokes in younger demographics have surged since the 1980s, now accounting for 10 to 15 percent of all stroke cases in the United States. A substantial proportion of these—30 to 50 percent—are cryptogenic, with no clear cause. As reported by Daily Mail, the study’s authors suggest that hormonal contraceptives could be a contributing factor in this unexplained trend.

Despite decades of growing concern, the widespread use of estrogen-based contraceptives continues. Critics point to longstanding underreporting of risks by pharmaceutical companies, while patients receive little more than fine-print warnings. The U.S. Food and Drug Administration has previously acknowledged links between hormonal contraceptives and blood clots, embolisms, and cardiovascular events, but these risks often remain understated during clinical consultations.

Non-Estrogen Alternatives Advised

Experts now recommend that women concerned about stroke risk consider alternatives to combined oral contraceptives. Safer options may include progestin-only pills, copper or hormonal intrauterine devices (IUDs), or barrier methods such as condoms. While less convenient, natural family planning methods carry no pharmaceutical risk and can be highly effective when followed correctly.

The broader issue, say researchers, is that these safer options are rarely emphasized in mainstream medical practice. Critics argue that this is symptomatic of a healthcare model shaped by pharmaceutical incentives, where products are often prioritized over patient-specific risk evaluations.

As reported by PharmaceuticalFraud.com, systemic industry practices have long skewed patient education and drug safety disclosures. The current findings add weight to that concern, especially for women facing life-altering cardiovascular events that may have been preventable.

Dr. Sezgin concluded, “Our findings should prompt more careful evaluation of stroke risk in young women, particularly those with additional risk factors.” Still, the extent to which physicians will incorporate these findings into prescribing practices remains uncertain.

For women using hormonal contraceptives, experts advise requesting the lowest possible dose, monitoring blood pressure routinely, and revisiting their options with a healthcare provider.

Ultimately, the study’s authors call for a more transparent, individualized approach to reproductive health—one that accounts for the growing body of evidence linking hormonal contraceptives to serious adverse outcomes.

As covered by DangerousMedicine.com, the need for informed consent and broader public awareness is more pressing than ever. The evidence now suggests that for some women, the risks of combined oral contraceptives may far outweigh the benefits.

Source: Natural News

Posted by yourNEWS Media Newsroom

Posted by yourNEWS Media Newsroom

yourNEWS.com is a premier news dissemination platform operating at local, state, and national levels. Our unwavering commitment lies in the restoration of journalistic integrity. We envision news delivery in its purest form: untainted by bias and firmly grounded in truth.

Embracing transparency, we refrain from censorship. By circumventing the gatekeepers of misinformation and government narratives, we empower 'the people' with the rightful control over the press. yourNEWS is on the cusp of reshaping the media landscape, cultivating the largest news platform globally. We are not just forecasting change—we're creating it.

(Note: Articles may not be original content. Reference byline for original source.)

[more]NEWS for YOU

Install [your]NEWS on your device!

Install
×